Stocks · Health care · Pharmaceutical Preparations

Contineum Therapeutics, Inc.

CTNM Clue Score32
United States Fiscal year ends December CIK 0001855175
13.38
+1.52%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
13.38 on 9 Oct 2026
18 13 9 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $11.93 14 Oct 2025 $11.67 15 Oct 2025 $12.32 16 Oct 2025 $12.46 17 Oct 2025 $11.70 20 Oct 2025 $11.09 21 Oct 2025 $11.06 22 Oct 2025 $11.03 23 Oct 2025 $11.12 24 Oct 2025 $11.05 27 Oct 2025 $11.21 28 Oct 2025 $11.03 29 Oct 2025 $10.90 30 Oct 2025 $10.54 31 Oct 2025 $11.01 3 Nov 2025 $10.65 4 Nov 2025 $10.39 5 Nov 2025 $10.44 6 Nov 2025 $11.01 7 Nov 2025 $10.93 10 Nov 2025 $10.85 11 Nov 2025 $10.96 12 Nov 2025 $11.47 13 Nov 2025 $10.90 14 Nov 2025 $10.66 17 Nov 2025 $11.15 18 Nov 2025 $11.51 19 Nov 2025 $12.43 20 Nov 2025 $12.22 21 Nov 2025 $10.95 24 Nov 2025 $10.36 25 Nov 2025 $10.71 26 Nov 2025 $10.76 28 Nov 2025 $11.07 1 Dec 2025 $10.99 2 Dec 2025 $10.49 3 Dec 2025 $11.12 4 Dec 2025 $10.98 5 Dec 2025 $11.04 8 Dec 2025 $12.25 9 Dec 2025 $12.50 10 Dec 2025 $12.52 11 Dec 2025 $13.07 12 Dec 2025 $11.63 15 Dec 2025 $11.58 16 Dec 2025 $11.55 17 Dec 2025 $11.48 18 Dec 2025 $11.39 19 Dec 2025 $11.74 22 Dec 2025 $12.26 23 Dec 2025 $12.31 24 Dec 2025 $12.68 26 Dec 2025 $12.41 29 Dec 2025 $12.07 30 Dec 2025 $11.40 31 Dec 2025 $11.43 2 Jan 2026 $11.39 5 Jan 2026 $10.00 6 Jan 2026 $9.49 7 Jan 2026 $9.56 8 Jan 2026 $9.17 9 Jan 2026 $9.31 12 Jan 2026 $9.17 13 Jan 2026 $10.90 14 Jan 2026 $11.76 15 Jan 2026 $11.84 16 Jan 2026 $11.74 20 Jan 2026 $11.85 21 Jan 2026 $12.20 22 Jan 2026 $12.63 23 Jan 2026 $12.99 26 Jan 2026 $12.94 27 Jan 2026 $14.09 28 Jan 2026 $14.43 29 Jan 2026 $14.60 30 Jan 2026 $14.26 2 Feb 2026 $14.38 3 Feb 2026 $15.21 4 Feb 2026 $14.80 5 Feb 2026 $14.48 6 Feb 2026 $15.00 9 Feb 2026 $15.27 10 Feb 2026 $15.75 11 Feb 2026 $15.26 12 Feb 2026 $14.88 13 Feb 2026 $14.44 17 Feb 2026 $14.69 18 Feb 2026 $15.22 19 Feb 2026 $16.00 20 Feb 2026 $15.58 23 Feb 2026 $15.64 24 Feb 2026 $15.93 25 Feb 2026 $15.78 26 Feb 2026 $15.78 27 Feb 2026 $15.34 2 Mar 2026 $15.34 3 Mar 2026 $14.10 4 Mar 2026 $14.86 5 Mar 2026 $13.81 6 Mar 2026 $13.88 9 Mar 2026 $13.54 10 Mar 2026 $13.41 11 Mar 2026 $14.98 12 Mar 2026 $13.86 13 Mar 2026 $13.00 16 Mar 2026 $13.37 17 Mar 2026 $13.22 18 Mar 2026 $12.22 19 Mar 2026 $12.11 20 Mar 2026 $12.21 23 Mar 2026 $12.42 24 Mar 2026 $12.33 25 Mar 2026 $13.28 26 Mar 2026 $13.65 27 Mar 2026 $13.34 30 Mar 2026 $12.46 31 Mar 2026 $13.06 1 Apr 2026 $13.45 2 Apr 2026 $13.44 6 Apr 2026 $13.44 7 Apr 2026 $12.73 8 Apr 2026 $12.79 9 Apr 2026 $12.83 10 Apr 2026 $12.87 13 Apr 2026 $12.76 14 Apr 2026 $12.97 15 Apr 2026 $13.25 16 Apr 2026 $13.30 17 Apr 2026 $13.53 20 Apr 2026 $13.47 21 Apr 2026 $13.15 22 Apr 2026 $12.96 23 Apr 2026 $12.42 24 Apr 2026 $12.41 27 Apr 2026 $12.97 28 Apr 2026 $12.54 29 Apr 2026 $12.04 30 Apr 2026 $12.82 1 May 2026 $13.20 4 May 2026 $14.15 5 May 2026 $14.39 6 May 2026 $14.94 7 May 2026 $14.63 8 May 2026 $14.53 11 May 2026 $13.65 12 May 2026 $13.66 13 May 2026 $14.15 14 May 2026 $14.21 15 May 2026 $13.72 18 May 2026 $12.86 19 May 2026 $12.76 20 May 2026 $13.39 21 May 2026 $14.37 22 May 2026 $13.86 26 May 2026 $13.70 27 May 2026 $13.44 28 May 2026 $13.31 29 May 2026 $13.49 1 Jun 2026 $13.09 2 Jun 2026 $12.38 3 Jun 2026 $12.48 4 Jun 2026 $12.34 5 Jun 2026 $11.49 8 Jun 2026 $11.53 9 Jun 2026 $11.43 10 Jun 2026 $11.30 11 Jun 2026 $11.86 12 Jun 2026 $11.88 15 Jun 2026 $12.72 16 Jun 2026 $12.40 17 Jun 2026 $12.16 18 Jun 2026 $11.94 22 Jun 2026 $11.62 23 Jun 2026 $11.91 24 Jun 2026 $12.82 25 Jun 2026 $13.36 26 Jun 2026 $14.19 29 Jun 2026 $15.00 30 Jun 2026 $16.39 1 Jul 2026 $15.24 2 Jul 2026 $15.10 6 Jul 2026 $15.53 7 Jul 2026 $14.56 8 Jul 2026 $15.65 9 Jul 2026 $15.45 10 Jul 2026 $15.19 13 Jul 2026 $14.62 14 Jul 2026 $14.57 15 Jul 2026 $14.63 16 Jul 2026 $14.01 17 Jul 2026 $14.23 20 Jul 2026 $13.53 21 Jul 2026 $13.90 22 Jul 2026 $14.73 23 Jul 2026 $14.37 24 Jul 2026 $14.06 27 Jul 2026 $13.86 28 Jul 2026 $14.16 29 Jul 2026 $14.38 30 Jul 2026 $15.75 31 Jul 2026 $15.49 3 Aug 2026 $15.93 4 Aug 2026 $15.90 5 Aug 2026 $15.27 6 Aug 2026 $15.35 7 Aug 2026 $15.04 10 Aug 2026 $14.49 11 Aug 2026 $14.82 12 Aug 2026 $14.98 13 Aug 2026 $15.30 14 Aug 2026 $14.19 17 Aug 2026 $14.53 18 Aug 2026 $14.50 19 Aug 2026 $16.02 20 Aug 2026 $16.02 21 Aug 2026 $17.19 24 Aug 2026 $16.63 25 Aug 2026 $17.05 26 Aug 2026 $17.02 27 Aug 2026 $17.25 28 Aug 2026 $17.05 31 Aug 2026 $16.24 1 Sep 2026 $16.55 2 Sep 2026 $17.24 3 Sep 2026 $17.57 4 Sep 2026 $16.70 8 Sep 2026 $15.94 9 Sep 2026 $15.14 10 Sep 2026 $14.66 11 Sep 2026 $14.82 14 Sep 2026 $14.82 15 Sep 2026 $13.82 16 Sep 2026 $13.76 17 Sep 2026 $13.21 18 Sep 2026 $13.53 21 Sep 2026 $13.55 22 Sep 2026 $13.40 23 Sep 2026 $12.51 24 Sep 2026 $12.49 25 Sep 2026 $12.56 28 Sep 2026 $12.73 29 Sep 2026 $11.50 30 Sep 2026 $13.42 1 Oct 2026 $12.99 2 Oct 2026 $13.12 5 Oct 2026 $12.72 6 Oct 2026 $12.65 7 Oct 2026 $12.73 8 Oct 2026 $13.18 9 Oct 2026 $13.38 Lorrain Daniel S. Chief Scientific Officer Sold on a plan $51.01K 23 Dec 2025 · at $12.23 · 2.5% of stake Watkins Tim CMO & Head of Development Sold on a plan $43.56K 29 Dec 2025 · at $12.06 · 100% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $43.54K 5 Jan 2026 · at $10.44 · 2.5% of stake Watkins Tim CMO & Head of Development Sold on a plan $51.19K 28 Jan 2026 · at $14.18 · 100% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $62.31K 3 Feb 2026 · at $14.94 · 2.6% of stake Stengone Carmine N. CEO and President Sold on a plan $6.40K 11 Feb 2026 · at $16.00 · 2.6% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $6.40K 11 Feb 2026 · at $16.00 · 0.3% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $1.60K 19 Feb 2026 · at $16.00 · 0.1% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $68.94K 24 Feb 2026 · at $16.03 · 2.7% of stake Stengone Carmine N. CEO and President Sold on a plan $70.49K 24 Feb 2026 · at $16.02 · 22.7% of stake Stengone Carmine N. CEO and President Sold on a plan $43.24K 25 Feb 2026 · at $16.02 · 15.3% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $61.23K 25 Feb 2026 · at $16.01 · 2.4% of stake Watkins Tim CMO & Head of Development Sold on a plan $54.22K 2 Mar 2026 · at $15.02 · 100% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $62.59K 2 Mar 2026 · at $15.01 · 2.7% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $56.01K 6 Apr 2026 · at $13.43 · 2.7% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $54.69K 1 May 2026 · at $13.12 · 2.8% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $54.86K 1 Jun 2026 · at $13.16 · 2.9% of stake Stengone Carmine N. CEO and President Sold on a plan $160.08K 30 Jun 2026 · at $16.01 · 36.7% of stake Watkins Tim CMO & Head of Development Sold on a plan $173.59K 30 Jun 2026 · at $16.02 · 54.7% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $462.29K 30 Jun 2026 · at $16.04 · 17.1% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $132.29K 1 Jul 2026 · at $15.84 · 5.8% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $16.24K 8 Jul 2026 · at $16.00 · 0.7% of stake Stengone Carmine N. CEO and President Sold on a plan $40.00K 8 Jul 2026 · at $16.00 · 12.7% of stake Lorrain Daniel S. Chief Scientific Officer Sold on a plan $400.00 9 Jul 2026 · at $16.00 · 0.0% of stake Stengone Carmine N. CEO and President Sold on a plan $40.03K 3 Aug 2026 · at $16.01 · 12.7% of stake Stengone Carmine N. CEO and President Sold on a plan $41.14K 8 Sep 2026 · at $16.46 · 12.7% of stake
0 buys0 sales at will26 planned sales

Key numbers

Fiscal year 2024, ended 31 Dec 2024, as filed
Revenue
$0.00
Net income
$42.26M
Free cash flow
$33.36M
Return on equity
-21.3%
Return on capital
-20.3%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
50M 23M FY23 Fiscal year 2023 Revenue $50.00M Net income $22.72M Margin 45.4% 0K -42M FY24 Fiscal year 2024 Revenue $0.00 Net income $42.26M Margin n/a · growth -100.0% 0K -60M FY25 Fiscal year 2025 Revenue $0.00 Net income $59.98M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
8 Sep 2026 Stengone Carmine N.
CEO and President
Sold on a plan $41.14K 12.7%
3 Aug 2026 Stengone Carmine N.
CEO and President
Sold on a plan $40.03K 12.7%
9 Jul 2026 Lorrain Daniel S.
Chief Scientific Officer
Sold on a plan $400.00 0.0%
8 Jul 2026 Stengone Carmine N.
CEO and President
Sold on a plan $40.00K 12.7%
8 Jul 2026 Lorrain Daniel S.
Chief Scientific Officer
Sold on a plan $16.24K 0.7%
1 Jul 2026 Lorrain Daniel S.
Chief Scientific Officer
Sold on a plan $132.29K 5.8%